Search results
Results From The WOW.Com Content Network
A newborn infant undergoing white-light phototherapy to treat neonatal jaundice. Light therapy is used to treat cases of neonatal jaundice. [44] Bilirubin, a yellow pigment normally formed in the liver during the breakdown of old red blood cells, cannot always be effectively cleared by a neonate's liver causing neonatal jaundice.
Crib A'Glow is a portable solar-powered phototherapy unit that uses blue LED lights to treat infants with jaundice. The device was invented by Virtue Oboro, a visual designer and mother whose newborn son had developed jaundice. Crib A'Glow has won multiple prizes for innovation.
Infant undergoing bili light therapy in a United States maternity ward. A bili light [ 1 ] [ 2 ] is a light therapy tool to treat newborn jaundice ( hyperbilirubinemia ). High levels of bilirubin can cause brain damage ( kernicterus ), leading to cerebral palsy , auditory neuropathy, gaze abnormalities and dental enamel hypoplasia .
Much like with phototherapy the level at which exchange transfusion should occur depends on the health status and age of the newborn. It should however be used for any newborn with a total serum bilirubin of greater than 428 μmol/L ( 25 mg/dL ). [25] [28]: 2533
If the bilirubin level is sufficiently high as to cause worry, it can be lowered via phototherapy in the first instance or an exchange transfusion if severely elevated. [citation needed] Phototherapy - Phototherapy is used for cord bilirubin of 3 or higher. Some doctors use it at lower levels while awaiting lab results. [19]
A neonatal intensive care unit (NICU), also known as an intensive care nursery (ICN), is an intensive care unit (ICU) specializing in the care of ill or premature newborn infants. The NICU is divided into several areas, including a critical care area for babies who require close monitoring and intervention, an intermediate care area for infants ...
Hemolytic disease of the fetus and newborn (HDN) is a condition where the passage of maternal antibodies results in the hemolysis of fetal/neonatal red cells. The antibodies can be naturally occurring such as anti-A, and anti-B, or immune antibodies developed following a sensitizing event. [ 38 ]
Hemolytic disease of the fetus and newborn (HDN) is a condition where the passage of maternal antibodies results in the hemolysis of fetal/neonatal red cells. The antibodies can be naturally occurring such as anti-A, and anti-B, or immune antibodies developed following a sensitizing event. [ 11 ]